Long-term support for opioid use disorder treatment
Part of Mental health clinical trials.
This study looks at long-term treatment support for people receiving medicine-assisted treatment for opioid use disorder. It may help by testing an approach to improve long-term outcomes while you receive buprenorphine or methadone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old
- You must be enrolled in REACH for buprenorphine or methadone treatment
- You must currently be unemployed
- You must not report recent hallucinations
- You must not be currently incarcerated (in prison)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a behavioral support program designed to help people newly starting buprenorphine treatment for opioid use disorder stay engaged with their care. If you've recently started buprenorphine or just been released from incarceration and are beginning treatment, this trial may help you maintain consistent medication use and reduce the risk of relapse.
This study tests whether talking regularly with someone who has recovered from opioid addiction helps you stay in buprenorphine treatment longer. Buprenorphine is a medication that reduces cravings and withdrawal, and peer support may help you stick with it.
This study tests whether extra support in community settings (like mobile units or outreach) helps people who are starting buprenorphine for opioid use disorder stay on treatment. It focuses on helping you continue your medication and stay healthy.
This study tests if a reward-based program (called contingency management) helps people stick with their medication for opioid use disorder (like buprenorphine or methadone) after an emergency department visit.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This study compares two medications, methadone and buprenorphine, to see which helps people stay in treatment for opioid use disorder. You may be eligible if you are starting a new treatment episode.
Hear when a new Drug Addiction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.